```json
[
    {
        "primary_name": "Upadacitinib",
        "candidates": ["Upadacitinib", "ABP 937", "Rinvoq"],
        "entity_name": "Upadacitinib",
        "type": "Drug",
        "description": "A Janus kinase (JAK) 1 inhibitor used for treating inflammatory bowel disease (IBD).",
        "is_ambiguous": false
    },
    {
        "primary_name": "Risankizumab",
        "candidates": ["Risankizumab", "ABBV-181", "Skyrizi"],
        "entity_name": "Risankizumab",
        "type": "Drug",
        "description": "An IL-23 inhibitor used for treating inflammatory bowel disease (IBD).",
        "is_ambiguous": false
    },
    {
        "primary_name": "Inflammatory Bowel Disease",
        "candidates": ["Inflammatory Bowel Disease (IBD)", "IBD"],
        "entity_name": "Inflammatory Bowel Disease (IBD)",
        "type": "Disease",
        "description": "A group of inflammatory conditions of the colon and small intestine.",
        "is_ambiguous": false
    },
    {
        "primary_name": "Crohn's Disease",
        "candidates": ["Crohn's disease", "Crohn disease", "Regional Enteritis"],
        "entity_name": "Crohn's disease",
        "type": "Disease",
        "description": "A type of inflammatory bowel disease that can affect any part of the gastrointestinal tract.",
        "is_ambiguous": false
    }
]
```